Rexulti (generic name: brexpiprazole) is an oral atypical antipsychotic approved for 3 uses at certain doses: to treat adults and children 13 years and older with schizophrenia, to treat adults as an add-on therapy to antidepressant therapy (ADT) for major depressive disorder (MDD), and to t...
such as Abilify or Abilify Maintena. If you've never received any form of aripiprazole, your doctor may first start you on an oral dose of aripiprazole for up to 2 weeks to make sure you tolerate it well.